Compare Celsius Holdings, Inc. (CELH) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Celsius Holdings, Inc. vs Johnson & Johnson — how do they compare? Celsius Holdings, Inc. trades at $27.72 (market cap $6.99B), while Johnson & Johnson trades at $261.31 (market cap $628.65B). The key difference: Johnson & Johnson is far larger — about 89.9× Celsius Holdings, Inc.'s market cap, and Johnson & Johnson pays a 2.05% dividend while Celsius Holdings, Inc. pays none. Which is the better fit depends on your goals.
| CELH | JNJ | |
|---|---|---|
Market Cap | $6.99B | $628.65B |
Sector | Consumer Staples | Health |
52-Week High | $64.86 | $267.24 |
52-Week Low | $23.77 | $174.16 |
Enterprise Value | $8.79B | $656.92B |
Volume | — | 6,156,228 |
Dividend Yield | — | 2.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CELH trades at $27.48, up 0.99% on the day, but remains under bearish technical pressure with key resistance at $29. The company reported Q2 2026 earnings that missed expectations, with revenue growth slowing to 11% year-over-year as core brand sales weakened, though Alani Nu and Rockstar acquisitions provided some offset. Net cash flow was negative $350.20 million in 2025 due to significant investing activities.
Outlook is mixed; strong analyst buy consensus (95.65%) and a $44.08 price target suggest long-term confidence in growth via PepsiCo partnership, but near-term risks include execution challenges, margin pressure, and ongoing investigations into management disclosures. The stock's high P/E of 122.13 reflects growth expectations that must materialize to justify valuation.
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Celsius Holdings, Inc.
Celsius Holdings Inc engages in the development, marketing, sale, and distribution of functional calorie-burning beverages. It offers flavors including cola, orange, wild berry and lemon iced tea and non-carbonated flavors such as Raspberry Acai Green Tea and Peach Mango Green Tea under the Celsius brand name. The company distributes its products through direct-store-delivery distributors, as well as directly to retailers across various retail segments, including supermarkets, convenience stores, drug stores, nutritional stores, mass merchants, health clubs, spas, gyms, military, and e-commerce websites.
Read more on CELH →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
